Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 19

Original Research

Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States

       
Total article views   HTML views PDF downloads Totals
2,079 Dovepress* 1,941+ 48 1,989
PubMed Central* 138 91 229
Totals 2,079 139 2,218
*Since 11 January 2024

View citations on PubMed Central and Google Scholar